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Over the past years considerable progress has been
made in the ﬁeld of CMR, which provides accurate
evaluation of left ventricular function particularly in
patients with ischemic heart disease and various
manifestations of cardiomyopathy [1–11]. Stress ﬁrst-
pass contrast-enhanced myocardial perfusion CMR
can be used to detect subendocardial ischemia and
recent studies have demonstrated the high diagnostic
accuracy of stress myocardial perfusion CMR for
detecting signiﬁcant coronary artery disease [12–17].
Magnetic resonance angiography (MRA) has been
introduced as a method that can provide visualization
of all three major coronary arteries, coronary anom-
alies, coronary bypasses and the aorta within a single
three-dimensional acquisition [18–21]. CMR has
become the ﬁrst choice imaging modality in complex
congenital heart disease [22–26] and imaging great
vessels [27–30].
Contrast-enhanced CMR has been used to visual-
ize the transmural extent of myocardial infarction
with high spatial resolution [31–35]. Infarcted myo-
cardium appears hyperenhanced compared with
normal myocardium when imaged by late enhance-
ment CMR. The transmural extent of delayed gado-
linium enhancement predicts functional outcome
after interventional procedures performed in patients
with acute myocardial infarction and chronic ische-
mic heart disease [36–42]. In this way, tissue
characterization of the myocardium has become a
major asset of CMR, providing unique information of
the structure of the myocardium both in normal and
abnormal conditions. In particular, late gadolinium
enhancement techniques make use of T1-weighted
images for tissue characterization and these tech-
niques are used regularly both in experimental
research and clinical cardiology.
For over 25 years it is known that in the acutely
infarcted heart the signal intensity in T2-weighted
images correlates well with myocardial edema
[43–49]. This ‘‘edema imaging’’ on T2-weighted
images has been shown to be dependent of infarct
age: edema-associated hyper-intense zones in T2-
weighted images resolve over time and the area of
T2 abnormality delineates the area at risk rather than
the infarcted area. An advantage of the clinical use of
T2-weighted images is the fact that T2-weighted
imaging detects acutely infarcted myocardium better
than chronic infarction, the latter being assessed best
with late gadolinium enhancement imaging.
In the current issue of the International Journal of
Cardiovascular Imaging, Joshi et al. [50] studied 8
patients, all female, with typical chest pain and
elevated troponin levels. At coronary angiography all
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signs of left ventricular ballooning consistent with the
syndrome of Takotsubo cardiomyopathy. Four
patients had apical ballooning and 4 patients had
midwall- or basal ballooning. CMR was performed at
hospital admission and the images were analyzed
with commercially available software (QMASS MR
Version 6.2.1, Medis, Leiden, the Netherlands). The
authors used a T2-weighted imaging technique and
the T2 signal was assessed both in normal and
dysfunctional myocardial regions. Interestingly, it
was found that T2-signal intensity was highest in the
dysfunctional segments, potentially indicating the
presence of myocardial edema in the affected areas of
patients with Takotsubo cardiomyopathy. Interest-
ingly, in the 5 patients who had a 2–3 week follow-up
CMR scan, there was normalization of the wall
motion abnormalities associated with a signiﬁcant
reduction in T2 signal intensity.
Takotsubo cardiomyopathy has recently been
recognized in patients with typical signs of acute
myocardial infarction mostly due to emotional stress.
In these patients the coronary arteries appear normal
but they show reversible wall motion abnormalities
[51–54]. As a result, it might be of great interest to
know the pathophysiological condition of the affected
myocardial tissue in the acute phase. Therefore,
several indications exist to use CMR-employed T2-
weighted images in the setting of the acute myocar-
dial infarction in these patients [55–57]. Whereas
decreased T2-weighted contrast ratios signiﬁcantly
correlate with the extent of persistent microvascular
obstruction and intra-myocardial hemorrhage, this
way of tissue characterization may contribute to early
detection of myocardial injury due to myocardial
infarction. In addition, CMR derived parameters may
be of great signiﬁcance in the follow-up of these
patients as they may show spontaneous recovery of
the cardiac abnormalities As a result, the article by
Yoshi et al. [50] clearly shows that the T2-weigthed
imaging technique may be a valuable approach in
patients who are suspected for Takotsubo cardiomy-
opathy, both in the acute and subacute phase.
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